Publication | Closed Access
Total syntheses of optically active 19-nor steroids. (+)-Estr-4-ene-3,17-dione and (+)-13.beta.-ethylgon-4-ene-3,17-dione
190
Citations
0
References
1975
Year
BiosynthesisBioorganic ChemistryEngineeringBiochemistryEnantioselective SynthesisNatural SciencesActive 19-Nor SteroidsAltmetric Attention ScoreMolecular BiologyOrganic ChemistrySocial Media PresenceStereoselective SynthesisChemistryNatural Product SynthesisSteroid MetabolismBiomolecular Engineering
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTTotal syntheses of optically active 19-nor steroids. (+)-Estr-4-ene-3,17-dione and (+)-13.beta.-ethylgon-4-ene-3,17-dioneRobert A. Micheli, Zoltan G. Hojos, Noal Cohen, David R. Parrish, Louis A. Portland, Werner Sciamanna, Melinda A. Scott, and Pius A. WehrliCite this: J. Org. Chem. 1975, 40, 6, 675–681Publication Date (Print):March 1, 1975Publication History Published online1 May 2002Published inissue 1 March 1975https://pubs.acs.org/doi/10.1021/jo00894a003https://doi.org/10.1021/jo00894a003research-articleACS PublicationsRequest reuse permissionsArticle Views3881Altmetric-Citations179LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose Get e-Alerts